Business Context and Reporting Period
This Form 6-K filing by Bon Natural Life Ltd covers the month of June 2022. The registrant is a foreign private issuer based in Xi'an, China, reporting material corporate governance changes regarding its Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or operational metrics.
Material Changes
- Board Resignation: Christopher Constable resigned from the Board of Directors on June 27, 2022. The company stated there was no known disagreement regarding operations, policies, or practices.
- Board Appointment: Effective June 28, 2022, Jeffrey J. Guzy was appointed as a new Director, a member of the Audit Committee, and Chairman of the Audit Committee.
- Qualifications: The Board determined Mr. Guzy qualifies as an "Independent Director" and an "audit committee financial expert" under Nasdaq rules.
Outlook, Risks, and Unusual Items
Management Commentary: The filing highlights Mr. Guzy's extensive background with international companies (including Loral Space, Sprint, Verizon, and IBM) and his current roles as an independent director for several public companies (Leatt Corp, Capstone Companies, Purebase Corp, Blue Star Foods, and Cojax Oil & Gas Corp).
Compensation and Unusual Items:
- Mr. Guzy will receive a stipend of $2,000 per month.
- He was granted options worth $50,000 (exercisable at $0.01 per share) and an additional $20,000 worth of options for his service as Audit Committee Chairman.
- Options vest in equal monthly installments over the initial year of service.
Risks and Contingencies: No specific financial risks or contingencies were disclosed in this filing.
Key Facts for Investor Verification
- Verify the independence status and potential conflicts of interest for the new Audit Committee Chairman, Jeffrey J. Guzy, given his multiple board seats in other public companies.
- Review the Director Service Agreement (Exhibit 10.1) for full terms regarding the $70,000 total option grant and vesting schedule.
- Confirm the reason for Christopher Constable's departure, despite the company's statement of no disagreement.
- Note that this filing contains no financial performance data; investors should refer to the most recent Form 20-F or quarterly reports for financial health.